Responses of the ambulatory arterial stiffness index and other measures of arterial function to antihypertensive drugs

Hypertension Research

Volumn 34, Issue 4, 2011, Pages 489-495

  Jin, Yu ^a   Thijs, Lutgarde ^a   Richart, Tom ^a,b   Li, Yan ^c   Dolan, Eamon ^d   Wang, Ji Guang ^c   Protogerou, Athanase ^e   O'Brien, Eoin ^f   Staessen, Jan A ^a,b   Safar, Michel E ^g  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d Stroke and Hypertension Unit   (Ireland)

^e UNIVERSITY OF ATHENS   (Greece)

^f UNIVERSITY COLLEGE DUBLIN   (Ireland)

^g HÔTEL DIEU   (France)

Author keywords

ambulatory arterial stiffness index; ambulatory blood pressure; aortic pulse wave velocity; arterial stiffness

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; INDAPAMIDE PLUS PERINDOPRIL;

ADULT; AMBULATORY ARTERIAL STIFFNESS INDEX; AORTIC PULSE WAVE VELOCITY; ARTERIAL STIFFNESS; ARTERIOVENTRICULAR COUPLING INDEX; ARTICLE; BLOOD PRESSURE MONITORING; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; FEMALE; FUNCTION TEST; HUMAN; HYPERTENSION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PULSE PRESSURE; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; ATENOLOL; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BRACHIAL ARTERY; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ELASTICITY; FEMALE; HUMANS; HYPERTENSION; INDAPAMIDE; MALE; MIDDLE AGED; PERINDOPRIL; TREATMENT OUTCOME;

EID: 79953724371     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2010.256     Document Type: Article

References (38)

1. Li Y, Wang JG, Dolan E, Gao PJ, Guo HF, Nawrot T, Stanton AV, Zhu DL, O'Brien E, Staessen JA. Ambulatory arterial stiffness index derived from 24-h ambulatory blood pressure monitoring. Hypertension 2006; 47: 359-364. (Pubitemid 43740275)
2. Dolan E, Thijs L, Li Y, Atkins N, McCormack P, McClory S, O'Brien E, Staessen JA, Stanton AV. Ambulatory arterial stiffness index as a predictor of cardiovascular mortality in the Dublin Outcome Study. Hypertension 2006; 47: 365-370. (Pubitemid 43740276)
3. MacWilliam JA, Melvin GS. Systolic and diastolic blood pressure estimation with special reference to the auditory method. Br Med J 1914; 1: 693-697.
4. O'Brien E, Asmar R, Beilin L, Imai Y, Mancia G, Mengden T, Myers M, Padfield P, Palatini P, Parati G, Pickering T, Redon J, Staessen J, Stergiou G, Verdecchia P, on behalf of the European Society of Hypertension Working Group on Blood Pressure Monitoring. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens 2005; 23: 697-701. (Pubitemid 40523262)
5. Leoncini G, Ratto E, Viazzi F, Vaccaro V, Parodi A, Falqui V, Conti N, Tomolillo C, Deferrari G, Pontremoli R. Increased arterial stiffness index is associated with target organ damage in primary hypertension. Hypertension 2006; 48: 397-403. (Pubitemid 44253732)
6. Hansen TW, Staessen JA, Torp-Pedersen C, Rasmussen S, Li Y, Dolan E, Thijs L, Wang JG, O'Brien E, Ibsen H, Jeppesen J. Ambulatory arterial stiffness index predicts stroke in a general population. J Hypertens 2006; 24: 2247-2253. (Pubitemid 44611034)
7. Kikuya M, Staessen JA, Ohkubo T, Thijs L, Metoki H, Asayama K, Obara T, Inoue R, Li Y, Dolan E, Hoshi H, Hashimoto J, Totsune K, Satoh H, Wang JG, O'Brien E, Imai Y. Ambulatory arterial stiffness index and 24-h ambulatory pulse pressure as predictors of mortality in Ohasama, Japan. Stroke 2007; 38: 1161-1166. (Pubitemid 351664280)
8. Laurent S. Surrogate measures of arterial stiffness : do they have additive predictive value or are they only surrogates of a surrogate ? Hypertension 2006; 47: 325-326. (Pubitemid 43740264)
9. Benetos A, Lacolley PJ. From 24-h blood pressure measurement to arterial siffness: a valid short cut ? Hypertension 2006; 47: 327-328. (Pubitemid 43740265)
10. Westerhof N, Lankhaar JW, Westerhof BE. The ambulatory arterial stiffness index is not a stiffness parameter but a ventriculo-arterial coupling factor. Hypertension 2007; 49: e7. (Pubitemid 46142989)
11. Hansen TW, Staessen JA, Torp-Pedersen C, Rasmussen S, Thijs L, Ibsen H, Jeppesen J. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 2006; 113: 664-670.
12. Asmar RG, London GM, O'Rourke ME, Safar ME. Improvement in blood pressure, arterial stiffness and wave reflection with a very-low-dose perindopril/indapamide combination in hypertensive patient : a comparison with atenolol. Hypertension 2001; 38: 922-926. (Pubitemid 34258694)
13. London GM, Asmar RG, O'Rourke MF, Safar ME, on behalf of the REASON project investigators. Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol. J Am Coll Cardiol 2004; 7: 92-99. (Pubitemid 38045921)
14. Mallion JM, Chamontin B, Asmar R, de Leeuw PW, O'Brien E, Duprez D, O'Rourke MF, Rahn KH, Romero J, Battegay E, Hitzenberger G, Safar ME, on behalf of the REASON Project. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/ indapamide first-line combination in hypertensive patients : the REASON study. Am J Hypertens 2004; 17: 245-251. (Pubitemid 38293330)
15. O'Brien E, Petrie J, Littler WA, de Swiet M, Padfield PL, Altman D, Bland M, Coats A, Atkins N. The British Hypertension Society protocol for the evaluation of blood pressure measuring devices. J Hypertens 1993; 11(Suppl 2): S43-S63.
16. The Association for the Advancement of Medical Instrumentation. American National Standard for Electronic or Automated Sphygmomanometers. The Association for the Advancement of Medical Instrumentation: Washington DC, USA, 1987.
17. Kikuya M, Hansen TW, Thijs L, Björklund-Bodegard K, Kuznetsova T, Ohkubo T, Richart T, Torp-Pedersen C, Lind L, Ibsen H, Imai Y, Staessen JA, on behalf of the International Database on ambulatory blood pressure in relation to Cardiovascular Outcome (IDACO) investigators. Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk. Circulation 2007; 115: 2145-2152.
18. Nichols WW, O'Rourke M (eds). Contours of pressure and flow waves in arteries. In: McDonalds Blood Flow in Arteries. Theoretical, Experimental and Clinical Principles, 5th edn. Hodder Arnold: London, UK, 2005, pp 165-191.
19. Westerhof N, Elzinga G. Normzlized input impedance and arterial decay time over heart period are independent of animal size. Am J Physiol 1991; 261: R126-R133.
20. Expert Panel on the Identification Evaluation and Treatment of Overweight in Adults. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults : executive summary. Am J Clin Nutr 1998; 68: 899-917.
21. Satoh H, Kishi R, Tsutsui H. Metabolic syndrome is a significant and independent risk factor for increased arterial stiffness in Japanese subjects. Hypertens Res 2009; 32: 1067-1071.
22. Van Den Meiracker AH, Man in 't Veld AJ, Boomsma F, Fischberg DJ, Molinoff PB, Schalekamp MADH. Hemodynamic and b-adrenergic receptor adaptations during long-term b-adrenoceptor blockade. Studies with acebutolol, atenolol, pindolol, and propranolol in hypertensive patients. Circulation 1989; 80: 903-914. (Pubitemid 19261638)
23. López-Sendón J, Swedberg K, McMurray J, Tamargo J, Maggioni AP, Dargie H, Tendera M, Waagstein F, Kjekshus J, Lechat P, Torp-Pedersen C. Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The task force on ACE-inhibitors of the European Society of Cardiology. Eur Heart J 2004; 25: 1454-1470.
24. Safar ME, Struijker Boudier H. Vascular development, pulse pressure, and the mechanisms of hypertension. Hypertension 2005; 46: 205-209. (Pubitemid 40946515)
25. Adiyaman A, Dechering DG, Boggia J, Li Y, Hansen TW, Kikuya M, Björklund-Bodegard K, Richart T, Thijs L, Torp-Pedersen C, Ohkubo T, Dolan E, Imai Y, Sandoya E, Ibsen H, Wang J, Lind L, O'Brien E, Thien T, Staessen JA, on behalf of the International Database on ambulatory blood pressure in relation to Cardiovascular Outcome (IDACO) investigators. Determinants of the ambulatory arterial stiffness index in 7604 subjects from 6 populations. Hypertension 2008; 52: 1038-1044.
26. Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, Hugues AD, Thurston H, O'Rourke M. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes : principal results of the Conduit Artery Function Evaluation ( CAFE) study. Circulation 2006; 113: 1213-1225.
27. Dahlöf B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, Collins R, Kjeldsen ̈ SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendrofluethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA) : a multicentre randomised controlled trial. Lancet 2005; 366: 895-906. (Pubitemid 41265663)
28. Thybo NK, Korsgaard N, Eriksen S, Christensen KL, Mulvany MJ. Dose-dependant effects of perindopril on blood pressure and small-artery structure. Hypertension 1994; 23: 659-666. (Pubitemid 24129363)
29. Schiffrin EL, Deng LY, Larochelle P. Effects of a b-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. Hypertension 1994; 23: 83-91. (Pubitemid 24022048)
30. Frisbee JC. Hypertension-independant microvascular rarefaction in the obese Zucker rat model of the metabolic syndrome. Microcirculation 2005; 12: 383-392. (Pubitemid 41122463)
31. Stepp DW, Pollock DM, Frisbee JC. Low-flow vascular remodeling in the metabolic syndrome X. Am J Physiol Heart Circ Physiol 2004; 286: H964-H970. (Pubitemid 38248610)
32. De Jongh RT, Serne EH, Ijzerman RG, De Vries G, Stehouwer CD. Impaired micro-vascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance. Circulation 2004; 109: 2529-2535. (Pubitemid 38720552)
33. Levy BI, Duriez M, Samuel JL. Coronary microvasculature alteration in hypertensive rats. Effect of treatment with a diuretic and an ACE inhibitor. Am J Hypertens 2001; 14: 7-13. (Pubitemid 32105911)
34. Zebekakis PE, Nawrot T, Thijs L, Balkestein EJ, Van der Heijden-Spek J, Van Bortel L, Struijker-Boudier HA, Safar ME, Staessen JA. Obesity is associated with increased arterial stiffness from adolescence until old age. J Hypertens 2005; 23: 1839-1846. (Pubitemid 41830424)
35. Castelli WP, Garrison RJ, Wilson PWF, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels. JAMA 1986; 256: 2835-2838. (Pubitemid 17178361)
36. Sharrett AR, Ballantyne CM, Coady SA, Heiss G, Sorlie PD, Catellier D, Patsch W. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I amd B, and HDL density subfractions. Circulation 2001; 104: 1108-1113. (Pubitemid 32830392)
37. Rimm EB, Williams P, Fosher K, Criqui M, Stampfer MJ. Moderate alcohol intake and lower risk of coronary heart disease:meta-analysis of effects on lipids and haemostatic factors. Br Med J 1999; 319: 1523-1528.
38. Thijs L, Hansen TW, Kikuya M, Björklund-Bodegard K, Li Y, Dolan E, Tikhonoff V, Sleidlerová J, Kuznetsova T, Stolarz K, Bianchi M, Richart T, Casiglia E, Malyutina S, Filipovskỳ J, Kawecka-Jaszcz K, Nikitin Y, Ohkubo T, Sandoya E, Wang JG, Torp-Pedersen C, Lind L, Ibsen H, Imai Y, Staessen JA, on behalf of the IDACO Investigators. The International Database of Ambulatory blood pressure in relation to Cardiovascular Outcome (IDACO) : protocol and research perspectives. Blood Press Monit 2007; 12: 255-262. (Pubitemid 47356413)